FANTI, STEFANO
FANTI, STEFANO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
Stefano Fanti; S. Fanti; FANTI S
A prospective study on the early evaluation of response to androgen receptor-targeted agents with 11C-Choline, 68Ga-PSMA, and 18F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experience
2024 Mollica, V.; Marchetti, A.; Fraccascia, N.; Nanni, C.; Tabacchi, E.; Malizia, C.; Argalia, G.; Rosellini, M.; Tassinari, E.; Paccapelo, A.; Fanti, S.; Massari, F.
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
2024 Oprea-Lager DE, MacLennan S, Bjartell A, Briganti A, Burger IA, de Jong I, De Santis M, Eberlein U, Emmett L, Fizazi K, Gillessen S, Herrmann K, Heskamp S, Iagaru A, Jereczek-Fossa BA, Kunikowska J, Lam M, Nanni C, O'Sullivan JM, Panebianco V, Sala E, Sathekge M, Sosnowski R, Tilki D, Tombal B, Treglia G, Tunariu N, Walz J, Yakar D, Dierckx R, Sartor O, Fanti S.
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?
2024 Vetrone L, Fortunati E, Castellucci P, Fanti S.
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy
2024 Voltin C.-A.; Paccagnella A.; Winkelmann M.; Heger J.-M.; Casadei B.; Beckmann L.; Herrmann K.; Dekorsy F.J.; Kutsch N.; Borchmann P.; Fanti S.; Kunz W.G.; Subklewe M.; Kobe C.; Zinzani P.L.; Stelljes M.; Roth K.S.; Drzezga A.; Noppeney R.; Rahbar K.; Reinhardt H.C.; von Tresckow B.; Seifert R.; Albring J.C.; Blumenberg V.; Farolfi A.; Flossdorf S.; Godel P.; Hanoun C.
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy
2024 Adebahr S, Althaus A, Scharl S, Strouthos I, Farolfi A, Serani F, Lanzafame H, Trapp C, Koerber SA, Peeken JC, Vogel MME, Vrachimis A, Spohn SKB, Grosu AL, Kroeze SGC, Guckenberger M, Fanti S, Hruby G, Emmett L, Belka C, Schmidt-Hegemann NS, Henkenberens C, Aebersold DM, Wiegel T, Afshar-Oromieh A, Zamboglou C, Shelan M.
68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
2023 Mei R.; Kessler L.; Pabst K.M.; Weber M.; Schmidkonz C.; Rischpler C.; Zacho H.D.; Hope T.; Schwarzenbock S.M.; Allen-Auerbach M.; Emmett L.; Ferdinandus J.; Unterrainer M.; Schaarschmidt B.M.; Umutlu L.; Farolfi A.; Castellucci P.; Nanni C.; Telo S.; Fanti S.; Herrmann K.; Fendler W.P.
A novel tool for predicting the dose distribution of non-sealed 188Re (Rhenium) resin in non-melanoma skin cancers (NMSC) patients
2023 Zagni F.; Vichi S.; Paolani G.; Santoro M.; Della Gala G.; Strolin S.; Castellucci P.; Vetrone L.; Fanti S.; Morganti A.G.; Strigari L.
A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer Patients
2023 Serani F.; Fendler W.P.; Castellucci P.; Berliner C.; Barbato F.; Herrmann K.; Farolfi A.; Fanti S.
Actionable imaging findings in the daily PET/CT scenario
2023 Mattana F.; Zanoni L.; Nanni C.; Mosconi C.; Brocchi S.; Golfieri R.; Fanti S.
Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial
2023 Guido, Alessandra; Cuicchi, Dajana; Castellucci, Paolo; Cellini, Francesco; Di Fabio, Francesca; Llimpe, Fabiola Lorena Rojas; Strigari, Lidia; Buwenge, Milly; Cilla, Savino; Deodato, Francesco; Macchia, Gabriella; Galietta, Erika; Golfieri, Rita; Ardizzoni, Andrea; Zagari, Rocco Maurizio; Fanti, Stefano; Poggioli, Gilberto; Fuccio, Lorenzo; Morganti, Alessio G
An Apparent Diffusion Coefficient-based machine learning model can improve Prostate Cancer detection in the grey area of the PI-RADS 3 category: a single-centre experience
2023 Caterina Gaudiano, Margherita Mottola, Lorenzo Bianchi, Beniamino Corcioni, Lorenzo Braccischi, Makoto Taninokuchi Tomassoni, Arrigo Cattabriga, Maria Adriana Cocozza, Francesca Giunchi, Riccardo Schiavina, Stefano Fanti, Michelangelo Fiorentino, Eugenio Brunocilla, Cristina Mosconi, Alessandro Bevilacqua
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients
2023 Ferrandez M.C.; Golla S.S.V.; Eertink J.J.; de Vries B.M.; Lugtenburg P.J.; Wiegers S.E.; Zwezerijnen G.J.C.; Pieplenbosch S.; Kurch L.; Huttmann A.; Hanoun C.; Duhrsen U.; de Vet H.C.W.; Hoekstra O.S.; Burggraaff C.N.; Bes A.; Heymans M.W.; Jauw Y.W.S.; Chamuleau M.E.D.; Barrington S.F.; Mikhaeel G.; Zucca E.; Ceriani L.; Carr R.; Gyorke T.; Czibor S.; Fanti S.; Kostakoglu L.; Loft A.; Hutchings M.; Lee S.T.; Zijlstra J.M.; Boellaard R.
Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors with the Clinical Application of FAPI Imaging?
2023 Bolton R.C.D.; Calapaqui Teran A.K.; Herrmann K.; Fanti S.; Giammarile F.
CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study
2023 Pensato U.; Amore G.; Muccioli L.; Sammali S.; Rondelli F.; Rinaldi R.; D'Angelo R.; Nicodemo M.; Mondini S.; Sambati L.; Asioli G.M.; Rossi S.; Santoro R.; Cretella L.; Ferrari S.; Spinardi L.; Faccioli L.; Fanti S.; Paccagnella A.; Pierucci E.; Casadei B.; Pellegrini C.; Zinzani P.L.; Bonafe M.; Cortelli P.; Bonifazi F.; Guarino M.
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge
2023 Vetrone, Luigia; Cuzzani, Giulia; Mei, Riccardo; Zanoni, Lucia; Bertaccini, Alessandro; Bianchi, Lorenzo; Castellucci, Paolo; Gaudiano, Caterina; Cappelli, Alberta; Giunchi, Francesca; Fanti, Stefano
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge
2023 Vetrone L.; Cuzzani G.; Mei R.; Zanoni L.; Bertaccini A.; Bianchi L.; Castellucci P.; Gaudiano C.; Cappelli A.; Giunchi F.; Fanti S.
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty
2023 Bamias A.; Stenzl A.; Brown S.L.; Albiges L.; Babjuk M.; Birtle A.; Briganti A.; Burger M.; Choudhury A.; Colecchia M.; De Santis M.; Fanti S.; Fonteyne V.; Gallucci M.; Rivas J.G.; Huddart R.; Junker K.; Kroeze S.; Loriot Y.; Merseburger A.; Montironi R.; Necchi A.; Oing C.; Oldenburg J.; Ost P.; Pinkawa M.; Ribal M.J.; Roupret M.; Thoeny H.; Zilli T.; Hoskin P.
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate Cancer
2023 Zamboglou C.; Peeken J.C.; Janbain A.; Katsahian S.; Strouthos I.; Ferentinos K.; Farolfi A.; Koerber S.A.; Debus J.; Vogel M.E.; Combs S.E.; Vrachimis A.; Morganti A.G.; Spohn S.K.B.; Shelan M.; Aebersold D.M.; Grosu A.L.; Ceci F.; Henkenberens C.; Kroeze S.G.C.; Guckenberger M.; Fanti S.; Belka C.; Bartenstein P.; Hruby G.; Scharl S.; Wiegel T.; Emmett L.; Arnoux A.; Schmidt-Hegemann N.S.
Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update
2023 Valzania C, Paccagnella A, Spadotto A, Ruotolo I, Bonfiglioli R, Fallani F, Fanti S, Galié N.
Errors in imaging reading and reporting
2023 Fanti, Stefano; Lalumera, Elisabetta
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A prospective study on the early evaluation of response to androgen receptor-targeted agents with 11C-Choline, 68Ga-PSMA, and 18F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experience | Mollica, V.; Marchetti, A.; Fraccascia, N.; Nanni, C.; Tabacchi, E.; Malizia, C.; Argalia, G.; Ro...sellini, M.; Tassinari, E.; Paccapelo, A.; Fanti, S.; Massari, F. | 2024-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | ESMO Open 2024.pdf; appendix.docx |
| European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer. | Oprea-Lager DE, MacLennan S, Bjartell A, Briganti A, Burger IA, de Jong I, De Santis M, Eberlein ...U, Emmett L, Fizazi K, Gillessen S, Herrmann K, Heskamp S, Iagaru A, Jereczek-Fossa BA, Kunikowska J, Lam M, Nanni C, O'Sullivan JM, Panebianco V, Sala E, Sathekge M, Sosnowski R, Tilki D, Tombal B, Treglia G, Tunariu N, Walz J, Yakar D, Dierckx R, Sartor O, Fanti S. | 2024-01-01 | EUROPEAN UROLOGY | - | 1.01 Articolo in rivista | 1-s2.0-S0302283823030920-main.pdf |
| Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT? | Vetrone L, Fortunati E, Castellucci P, Fanti S. | 2024-01-01 | SEMINARS IN NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy | Voltin C.-A.; Paccagnella A.; Winkelmann M.; Heger J.-M.; Casadei B.; Beckmann L.; Herrmann K.; D...ekorsy F.J.; Kutsch N.; Borchmann P.; Fanti S.; Kunz W.G.; Subklewe M.; Kobe C.; Zinzani P.L.; Stelljes M.; Roth K.S.; Drzezga A.; Noppeney R.; Rahbar K.; Reinhardt H.C.; von Tresckow B.; Seifert R.; Albring J.C.; Blumenberg V.; Farolfi A.; Flossdorf S.; Godel P.; Hanoun C. | 2024-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | Voltin_2024.pdf; 259_2023_6554_MOESM1_ESM.docx |
| The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy | Adebahr S, Althaus A, Scharl S, Strouthos I, Farolfi A, Serani F, Lanzafame H, Trapp C, Koerber S...A, Peeken JC, Vogel MME, Vrachimis A, Spohn SKB, Grosu AL, Kroeze SGC, Guckenberger M, Fanti S, Hruby G, Emmett L, Belka C, Schmidt-Hegemann NS, Henkenberens C, Aebersold DM, Wiegel T, Afshar-Oromieh A, Zamboglou C, Shelan M. | 2024-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | s00259-023-06438-3.pdf; 259_2023_6438_MOESM1_ESM.png |
| 68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study | Mei R.; Kessler L.; Pabst K.M.; Weber M.; Schmidkonz C.; Rischpler C.; Zacho H.D.; Hope T.; Schwa...rzenbock S.M.; Allen-Auerbach M.; Emmett L.; Ferdinandus J.; Unterrainer M.; Schaarschmidt B.M.; Umutlu L.; Farolfi A.; Castellucci P.; Nanni C.; Telo S.; Fanti S.; Herrmann K.; Fendler W.P. | 2023-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | 1043.full.pdf |
| A novel tool for predicting the dose distribution of non-sealed 188Re (Rhenium) resin in non-melanoma skin cancers (NMSC) patients | Zagni F.; Vichi S.; Paolani G.; Santoro M.; Della Gala G.; Strolin S.; Castellucci P.; Vetrone L....; Fanti S.; Morganti A.G.; Strigari L. | 2023-01-01 | MEDICAL PHYSICS | - | 1.01 Articolo in rivista | Medical Physics - 2023 - Zagni - A novel tool for predicting the dose distribution of non‐sealed 188Re Rhenium resin in.pdf; mp16346-sup-0001-suppmat.docx |
| A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer Patients | Serani F.; Fendler W.P.; Castellucci P.; Berliner C.; Barbato F.; Herrmann K.; Farolfi A.; Fanti S. | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-15-02208.pdf |
| Actionable imaging findings in the daily PET/CT scenario | Mattana F.; Zanoni L.; Nanni C.; Mosconi C.; Brocchi S.; Golfieri R.; Fanti S. | 2023-01-01 | CLINICAL AND TRANSLATIONAL IMAGING | - | 1.01 Articolo in rivista | - |
| Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial | Guido, Alessandra; Cuicchi, Dajana; Castellucci, Paolo; Cellini, Francesco; Di Fabio, Francesca; ...Llimpe, Fabiola Lorena Rojas; Strigari, Lidia; Buwenge, Milly; Cilla, Savino; Deodato, Francesco; Macchia, Gabriella; Galietta, Erika; Golfieri, Rita; Ardizzoni, Andrea; Zagari, Rocco Maurizio; Fanti, Stefano; Poggioli, Gilberto; Fuccio, Lorenzo; Morganti, Alessio G | 2023-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | Guido A et al, 2023.pdf |
| An Apparent Diffusion Coefficient-based machine learning model can improve Prostate Cancer detection in the grey area of the PI-RADS 3 category: a single-centre experience | Caterina Gaudiano, Margherita Mottola, Lorenzo Bianchi, Beniamino Corcioni, Lorenzo Braccischi, M...akoto Taninokuchi Tomassoni, Arrigo Cattabriga, Maria Adriana Cocozza, Francesca Giunchi, Riccardo Schiavina, Stefano Fanti, Michelangelo Fiorentino, Eugenio Brunocilla, Cristina Mosconi, Alessandro Bevilacqua | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Bevilacqua - An Apparent Diffusion Coefficient-Based Machine Learning.2023.pdf |
| An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients | Ferrandez M.C.; Golla S.S.V.; Eertink J.J.; de Vries B.M.; Lugtenburg P.J.; Wiegers S.E.; Zwezeri...jnen G.J.C.; Pieplenbosch S.; Kurch L.; Huttmann A.; Hanoun C.; Duhrsen U.; de Vet H.C.W.; Hoekstra O.S.; Burggraaff C.N.; Bes A.; Heymans M.W.; Jauw Y.W.S.; Chamuleau M.E.D.; Barrington S.F.; Mikhaeel G.; Zucca E.; Ceriani L.; Carr R.; Gyorke T.; Czibor S.; Fanti S.; Kostakoglu L.; Loft A.; Hutchings M.; Lee S.T.; Zijlstra J.M.; Boellaard R. | 2023-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | s41598-023-40218-1.pdf; file supplementari.zip |
| Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors with the Clinical Application of FAPI Imaging? | Bolton R.C.D.; Calapaqui Teran A.K.; Herrmann K.; Fanti S.; Giammarile F. | 2023-01-01 | CLINICAL NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study | Pensato U.; Amore G.; Muccioli L.; Sammali S.; Rondelli F.; Rinaldi R.; D'Angelo R.; Nicodemo M.;... Mondini S.; Sambati L.; Asioli G.M.; Rossi S.; Santoro R.; Cretella L.; Ferrari S.; Spinardi L.; Faccioli L.; Fanti S.; Paccagnella A.; Pierucci E.; Casadei B.; Pellegrini C.; Zinzani P.L.; Bonafe M.; Cortelli P.; Bonifazi F.; Guarino M. | 2023-01-01 | JOURNAL OF NEUROLOGY | - | 1.01 Articolo in rivista | - |
| Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge | Vetrone, Luigia; Cuzzani, Giulia; Mei, Riccardo; Zanoni, Lucia; Bertaccini, Alessandro; Bianchi, ...Lorenzo; Castellucci, Paolo; Gaudiano, Caterina; Cappelli, Alberta; Giunchi, Francesca; Fanti, Stefano | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Case Report PSMA.pdf |
| Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge | Vetrone L.; Cuzzani G.; Mei R.; Zanoni L.; Bertaccini A.; Bianchi L.; Castellucci P.; Gaudiano C....; Cappelli A.; Giunchi F.; Fanti S. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-13-1101221.pdf |
| Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty | Bamias A.; Stenzl A.; Brown S.L.; Albiges L.; Babjuk M.; Birtle A.; Briganti A.; Burger M.; Choud...hury A.; Colecchia M.; De Santis M.; Fanti S.; Fonteyne V.; Gallucci M.; Rivas J.G.; Huddart R.; Junker K.; Kroeze S.; Loriot Y.; Merseburger A.; Montironi R.; Necchi A.; Oing C.; Oldenburg J.; Ost P.; Pinkawa M.; Ribal M.J.; Roupret M.; Thoeny H.; Zilli T.; Hoskin P. | 2023-01-01 | EUROPEAN UROLOGY | - | 1.01 Articolo in rivista | - |
| Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate Cancer | Zamboglou C.; Peeken J.C.; Janbain A.; Katsahian S.; Strouthos I.; Ferentinos K.; Farolfi A.; Koe...rber S.A.; Debus J.; Vogel M.E.; Combs S.E.; Vrachimis A.; Morganti A.G.; Spohn S.K.B.; Shelan M.; Aebersold D.M.; Grosu A.L.; Ceci F.; Henkenberens C.; Kroeze S.G.C.; Guckenberger M.; Fanti S.; Belka C.; Bartenstein P.; Hruby G.; Scharl S.; Wiegel T.; Emmett L.; Arnoux A.; Schmidt-Hegemann N.S. | 2023-01-01 | JAMA NETWORK OPEN | - | 1.01 Articolo in rivista | zamboglou_2023_oi_230452_1683899167.63195.pdf; jamanetwopen-e2314748-s001.zip |
| Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update | Valzania C, Paccagnella A, Spadotto A, Ruotolo I, Bonfiglioli R, Fallani F, Fanti S, Galié N. | 2023-01-01 | JOURNAL OF NUCLEAR CARDIOLOGY | - | 1.01 Articolo in rivista | - |
| Errors in imaging reading and reporting | Fanti, Stefano; Lalumera, Elisabetta | 2023-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |